Cadre Holdings, Inc. Research and Development Expense
Cadre Holdings, Inc. (CDRE) reported Research and Development Expense of $11.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-03-10
- Cadre Holdings, Inc. research and development expense for fiscal 2025 was $11.40M, a 35.99% increase from fiscal 2024.
- Cadre Holdings, Inc. research and development expense for fiscal 2024 was $8.38M, a 20.51% increase from fiscal 2023.
- Cadre Holdings, Inc. research and development expense for fiscal 2023 was $6.95M, a 1.86% decline from fiscal 2022.
- Cadre Holdings, Inc. research and development expense for fiscal 2022 was $7.09M, a 9.69% increase from fiscal 2021.
| Period end | Research and Development Expense 12 month |
|---|---|
| 2025-12-31 | $11.40M 10-K · filed 2026-03-10 |
| 2024-12-31 | $8.38M 10-K · filed 2026-03-10 |
| 2023-12-31 | $6.95M 10-K · filed 2026-03-10 |
| 2022-12-31 | $7.09M 10-K · filed 2025-03-11 |
| 2021-12-31 | $6.46M 10-K · filed 2024-03-12 |
| 2020-12-31 | $5.63M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |